Purdue Pharma has reached a tentative deal to settle a series of opioid lawsuits. The settlement is the latest in what could be an ongoing legal battle between Purdue, which makes OxyContin, and several states that have sued it over its marketing practices. A new firm under different ownership would sell OxyContin and other drugs, with profits going to plaintiffs, who would get $12bn over a period of time.
Purdue Pharma has reached a tentative deal to settle a series of opioid lawsuits. Around two dozen states could be close to agreeing to a settlement that would put the OxyContin manufacturer, owned by the Sackler family, into bankruptcy. A new firm under different ownership would sell OxyContin and other drugs, with profits going to plaintiffs, who would get $12bn over a period of time.